Welcome to LookChem.com Sign In|Join Free

CAS

  • or

913837-98-6

ethyl 2-cyano-2-(4,5-diMethoxy-2-nitrophenyl)acetate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

913837-98-6

Post Buying Request

913837-98-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

913837-98-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 913837-98-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,3,8,3 and 7 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 913837-98:
(8*9)+(7*1)+(6*3)+(5*8)+(4*3)+(3*7)+(2*9)+(1*8)=196
196 % 10 = 6
So 913837-98-6 is a valid CAS Registry Number.

913837-98-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 2-cyano-2-(4,5-dimethoxy-2-nitro-phenyl)-acetate

1.2 Other means of identification

Product number -
Other names ETHYL 2-CYANO-2-(4,5-DIMETHOXY-2-NITROPHENYL)ACETATE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:913837-98-6 SDS

913837-98-6Relevant articles and documents

PROTEIN KINASE INHIBITORS

-

, (2008/06/13)

Protein kinase inhibitors are disclosed having utility in the treatment of protein kinase-mediated diseases and conditions, such as cancer. The compounds of this invention have the structure (I) including stereoisomers, prodrugs and pharmaceutically accep

PROTEIN KINASE INHIBITORS

-

Page/Page column 75, (2008/06/13)

Protein kinase inhibitors are disclosed having utility in the treatment of protein kinase-mediated diseases and conditions, such as cancer. The compounds of this invention have the following structure (I) including steroisomers, prodrugs and pharmaceutica

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 913837-98-6